GLP-1 Receptor Agonists and Anaesthesia: Aspiration Risk in a UK Multicentre Study

TopMedTalk presents a 34-minute interview recorded at the 8th Collaborative Clinical Trials in Anesthesiology meeting in Prato, Italy. Hosts Desiree Chappell and Mark Priestley interview Professor Karim El-Boghdadly, a Consultant Anaesthetist at Guy's and St Thomas' NHS Foundation Trust and Honorary Reader at King's College London, about the perioperative risks of GLP-1 receptor agonists—drugs increasingly used for diabetes and weight management. El-Boghdadly discusses the expanding clinical use of GLP-1 agonists and their mechanism of delayed gastric emptying, which creates aspiration risk during anesthesia. He challenges earlier guidance recommending patients hold GLP-1 for a week before surgery, arguing this is often impractical. The core of the episode centers on findings from a large UK trainee research network observational study spanning approximately 130 hospitals and 47,000 cases, including roughly 1,300 GLP-1 patients. The headline finding: an unadjusted 11-fold higher aspiration and regurgitation rate in GLP-1 users (approximately 1 in 70 cases) compared to non-users (approximately 1 in 800), with about half of these events occurring during emergence and extubation—the critical moment when patients wake from anesthesia. The discussion emphasizes practical perioperative risk assessment and extubation planning strategies. El-Boghdadly notes the surprisingly low uptake of gastric ultrasound—a technique that could help assess gastric contents and inform anesthetic decisions. The episode concludes by highlighting the need for future randomized controlled trials to establish definitive causation and optimal management protocols. The episode is tightly focused on a single, clinically significant topic with a clear research foundation. It provides actionable context for anesthesiologists and perioperative teams managing patients on GLP-1 therapy. The guest is highly credentialed with direct involvement in the research being discussed, lending authority to the presentation. The show notes include a direct link to the published paper, supporting transparency and allowing listeners to verify claims. The content is specialized and technical, aimed squarely at healthcare professionals rather than a general audience, but delivers substantive, evidence-based information without apparent padding or tangents.

Verdict: A tightly focused, evidence-based episode featuring a highly credentialed expert discussing significant clinical research with clear practical implications for anesthesiologists.

Health & Fitness rubric

• Evidence-based claims 5/5 20%

  Discussion grounded in a large observational study (47,000 cases across 130 hospitals) with specific quantified findings; acknowledges limitations by noting results are unadjusted and calls for future RCTs.

• Expert credentials 5/5 20%

  Guest is a Consultant Anaesthetist, Clinical Lead at a major NHS trust, Honorary Reader at King's College London, and directly involved in the research being discussed.

• Safe and practical advice 4/5 15%

  Emphasizes risk assessment and extubation planning without recommending extreme measures; challenges impractical guidance; notes low uptake of gastric ultrasound as a practical gap rather than prescribing risky alternatives.

• Substance 4/5 15%

  Dense with specific data (11-fold risk increase, 1 in 70 vs 1 in 800 rates, emergence timing) and clinical context; limited detail on extubation strategies or management specifics, but focused and substantive overall.

• Delivers on its title 5/5 15%

  Title promises discussion of GLP-1 agonists and aspiration risk in a UK multicentre study; episode directly presents the study findings, mechanisms, and perioperative implications as promised.

• Value for time 4/5 15%

  34 minutes is reasonable for a detailed research discussion with expert interview; no obvious padding evident from show notes, though without hearing the episode some pacing assessment is limited.

How we score Health & Fitness

Worth it if you are an anesthesiologist, perioperative clinician, or healthcare professional managing patients on GLP-1 therapy and need current evidence on aspiration risk.

Based on the episode description. AI-generated; it can be wrong.